Clinical Trial Update: An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating Etanercept for the treatment of psoriasis, sponsored by Amgen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 3 | Status: COMPLETED